Safe‐Dose Thrombolysis Plus Rivaroxaban for Moderate and Severe Pulmonary Embolism: Drip, Drug, and Discharge

Conclusions“Safe dose” thrombolysis plus rivaroxaban is highly safe and effective in the treatment of moderate and severe PE, leading to favorable early and intermediate‐term outcomes and early discharge.

Source: Clinical Cardiology - October 7, 2013 Category: Cardiology Authors: Mohsen Sharifi, Curt Bay, Frederic Schwartz, Laura Skrocki Tags: Clinical Investigation Source Type: research